Pre-made Arcitumomab benchmark antibody (Radiolabelled antibody, anti-CEACAM5/CD66e therapeutic antibody, Anti-CEA Antibody) for drug discovery and mechanism of action (MOA) research

Pre-made Arcitumomab benchmark antibody (Radiolabelled antibody, anti-CEACAM5/CD66e therapeutic antibody, Anti-CEA Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Technetium (99mTc) arcitumomab is a drug used for the diagnostic imaging of colorectal cancers, marketed by Immunomedics.[1] It consists of the Fab' fragment of a monoclonal antibody (arcitumomab, trade name CEA-Scan) and a radionuclide, technetium-99m.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-738-1mg	1mg	3090
GMP-Bios-INN-738-10mg	10mg	Inquiry
GMP-Bios-INN-738-100mg	100mg	Inquiry
GMP-Bios-INN-738-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Arcitumomab Biosimilar, Radiolabelled Antibody, Anti-CEACAM5/CD66e Antibody: Anti-CEA therapeutic antibody
INN Name	Arcitumomab
Target	CEACAM5/CD66e
Format	Radiolabelled antibody
Derivation	Mus musculus
Species Reactivity	human
CH1 Isotype	Fab' - G1 - nd
VD LC	Fab' - G1 - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Immunomedics Inc. (Morris Plains NJ USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0